Severity of Brugada syndrome disease manifestation and risk of new-onset depression or anxiety: a Danish nationwide study
Europace · 2023
DOI: 10.1093/europace/euad112 ↗Kurz gefasst
Kommentar in der Zeitschrift Europace, 2023. Verfasst von Camilla H B Jespersen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark. Hauptthemen laut MEDLINE: Brugada Syndrome. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novo Nordisk Foundation, John og Birth Meyer Foundation.
Themen: Depression
Abstract (Originalsprache)
Aims
Reduced psychological health is associated with adverse patient outcomes and higher mortality. We aimed to examine if a Brugada syndrome (BrS) diagnosis and symptomatic disease presentation were associated with an increased risk of new-onset depression or anxiety and all-cause mortality. Methods and results All Danish patients diagnosed with BrS (2006–2018) with no history of psychiatric disease and available for ≥6 months follow-up were identified using nationwide registries and followed for up to 5 years after diagnosis. The development of clinical depression or anxiety was evaluated using the prescription of medication and diagnosis codes. Factors associated with developing new-onset depression or anxiety were determined using a multivariate Cox proportional hazards regression model. Disease manifestation was categorized as symptomatic (aborted cardiac arrest, ventricular tachycardia, or syncope) or asymptomatic/unspecified at diagnosis. A total of 223 patients with BrS and no history of psychiatric disease were identified (72.6% male, median age at diagnosis 46 years, 45.3% symptomatic). Of these, 15.7% (35/223) developed new-onset depression or anxiety after BrS diagnosis (median follow-up 5.0 years). A greater proportion of symptomatic patients developed new-onset depression or anxiety compared with asymptomatic patients [21/101 (20.8%) and 14/122 (11.5%), respectively, P = 0.08]. Symptomatic disease presentation (HR 3.43, 1.46–8.05) and older age (lower vs. upper tertile: HR 4.41, 1.42–13.63) were significantly associated with new-onset depression or anxiety. All-cause mortality in this group of patients treated according to guidelines was low (n = 4, 1.8%); however, 3/4 developed depression or anxiety before death.
Conclusion
Approximately, one-sixth of patients with BrS developed new-onset depression or anxiety following a diagnosis of BrS. Symptomatic BrS disease manifestation was significantly associated with new-onset depression or anxiety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.
- Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Gentofte Hospitalsvej 1, 2900 Hellerup, Denmark.
- Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark.
- Department fo Cardiology, Odense University Hospital, J B Winsløws Vej 4, 5000 Odense C, Denmark.
- Department of Cardiology, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark.
- Department of Clinical Medicine, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark.
ORCID-Profile: Camilla H B Jespersen, Johanna Krøll, Priya Bhardwaj, Bo Gregers Winkel, Christian Jøns, Jens Kristensen, Jens Brock Johansen, Berit T Philbert, Sam Riahi, Christian Torp-Pedersen, Lars Køber, Jacob Tfelt-Hansen, Peter E Weeke
Förderung
- Novo Nordisk Foundation
- John og Birth Meyer Foundation
Zitieren
APA
Jespersen, C. H. B., Krøll, J., Bhardwaj, P., Winkel, B. G., Jacobsen, P. K., Jøns, C., Haarbo, J., Kristensen, J., Johansen, J. B., Philbert, B. T., Riahi, S., Torp-Pedersen, C., Køber, L., Tfelt-Hansen, J., & Weeke, P. E. (2023). Severity of Brugada syndrome disease manifestation and risk of new-onset depression or anxiety: a Danish nationwide study. Europace. https://doi.org/10.1093/europace/euad112
Vancouver
Jespersen CHB, Krøll J, Bhardwaj P, Winkel BG, Jacobsen PK, Jøns C, et al. Severity of Brugada syndrome disease manifestation and risk of new-onset depression or anxiety: a Danish nationwide study. Europace. 2023. doi:10.1093/europace/euad112
BibTeX
@article{Jespersen2023,
author = {Jespersen, Camilla H B and Krøll, Johanna and Bhardwaj, Priya and Winkel, Bo Gregers and Jacobsen, Peter Karl and Jøns, Christian and Haarbo, Jens and Kristensen, Jens and Johansen, Jens Brock and Philbert, Berit T and Riahi, Sam and Torp-Pedersen, Christian and Køber, Lars and Tfelt-Hansen, Jacob and Weeke, Peter E},
title = {Severity of Brugada syndrome disease manifestation and risk of new-onset depression or anxiety: a Danish nationwide study},
journal = {Europace},
year = {2023},
doi = {10.1093/europace/euad112}
}
EUVIMED